Quantcast

Latest Tianyin Pharmaceutical Co. Inc. Stories

2010-05-11 23:00:00

CHENGDU, China, May 12 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a biopharmaceutical company that specializes in the modernized traditional Chinese medicine ("TCM") and branded generics today announced fiscal results for its third quarter ended March 31, 2010. Third quarter fiscal year 2010 ending March 31, 2010 financial highlights -- Q3 FY2010 revenue increased 60% year over year to $15.9 million, net Income Increased 53% to...

2010-05-07 16:00:00

CHENGDU, China, May 7 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a biopharmaceutical company that develops, manufactures and sells modernized traditional Chinese medicine ("TCM") and branded generics based in Chengdu, China, today announced that the senior management will host a conference call to discuss its fiscal 2010 third quarter results at 9:00 a.m. ET on Wednesday, May 12, 2010. Interested parties may access the call by dialing...

2010-04-21 20:00:00

CHENGDU, Sichuan, China, April 21 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical (NYSE Amex: TPI) was invited by Sino American Biopharmaceutical Association (SABPA) to present at its 5th Annual Biomedical Forum held at Irvine, California on April 24th, 2010. SABPA Biomedical forum focuses on innovations in pharmaceutical and biotechnology industries, as well as business opportunities to thrive in the new economy. The forum provides an attractive platform for entrepreneurs,...

2010-04-04 20:00:00

SUZHOU, China, April 4 /PRNewswire-Asia/ -- Cold Spring Harbor Asia (CSHA) is the Asia hub of Cold Spring Harbor Laboratory (CSHL), which is headed by the DNA structure discover, Dr. James D. Watson and President and CEO of CSHL, Dr. Bruce Stillman, who spearhead the effort in molecular medicine and genetics for better diagnostics and treatments for neurological diseases, cancer and other major causes of human suffering. Home to seven Nobel laureates, CSHL has played a pivotal role in the...

2010-03-11 12:30:00

CHENGDU, China, March 11 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Alternext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced it will present at 22nd Annual ROTH Capital Partners (ROTH) OC Growth Stock Conference being held March 15-17, 2010 in Dana Point, California. Presentation details are noted below. Date: Tuesday, March 16, 2010 Time: 10:30 AM PST (Track 3)...

2010-03-03 10:30:00

BEIJING, March 3 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Alternext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced it will present at the Rodman & Renshaw Annual China Investment Conference being held March 7-9 in Beijing, China. Presentation details are noted below. Date: March 9, 2010 Time: 3:40 pm Beijing Time Location: Ballroom IIi, The Regent...

2010-02-09 07:30:00

CHENGDU, China, Feb. 9 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and Western Pharmaceuticals based in Chengdu, China, today announced that it expects operational benefits from the recently published Guide to Reform of Pricing Mechanism of Medicine and Medical Services by the Chinese government. On November 9, 2009, the Chinese National Development and Reform...

2010-02-08 15:29:00

CHENGDU, China, Feb. 8 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Alternext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced fiscal results for its second quarter ended December 31, 2009. -- Q2 2010 Revenue Increased 47.9% to $14.9 Million, Net Income Increased 24.8% to $2.6 Million with adjusted EPS of $0.11 on a diluted basis -- Cash and Equivalents of $19.9 Million...

2010-02-02 07:00:00

CHENGDU, China, Feb. 2 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and Western Pharmaceuticals based in Chengdu, China, today announced that management will host a conference call to discuss its fiscal 2010 second quarter results at 4:30 p.m. ET on Monday, February 8, 2010. Financial results will also be released that day. Interested parties may access the call by...

2010-01-13 08:00:00

CHENGDU, China, Jan. 13 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and Western Pharmaceuticals based in Chengdu, China, today announced that it has received approvals from the Chinese State Food and Drug Administration (SFDA) to produce both Ofloxacin Tablets (SFDA approval number H20094038) and Fleroxacin Tablets (SFDA approval number H2009S03440). Ofloxacin is a...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related